This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004; 364: 2097-105. doi: 10.1016/S0140-6736(04)17550-8Steliarova-FoucherEStillerCKaatschPBerrinoFCoeberghJWLacourBet alGeographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study2004364209710510.1016/S0140-6736(04)17550-815589307Open DOISearch in Google Scholar
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. EUROCARE Working Group. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol 2013; 15: 35-47. doi: 10.1016/S1470-2045(13)70548-5GattaGBottaLRossiSAareleidTBielska-LasotaMClavelJet alEUROCARE Working Group201315354710.1016/S1470-2045(13)70548-524314616Open DOISearch in Google Scholar
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al; Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82. doi: 10.1056/NEJMsa060185OeffingerKCMertensACSklarCAKawashimaTHudsonMMMeadowsATetal; Childhood Cancer Survivor StudyChronic health conditions in adult survivors of childhood cancer200635515728210.1056/NEJMsa06018517035650Open DOISearch in Google Scholar
Vassal G, Schrappe M, Pritchard-Jones K, Arnold F, Basset L, Biondi A, et al. The SIOPE strategic plan: A European cancer plan for children and adolescents. J Cancer Policy 2016; 8: 17-32. doi: 10.1016/j.jcpo.2016.03.007VassalGSchrappeMPritchard-JonesKArnoldFBassetLBiondiAet alThe SIOPE strategic plan: A European cancer plan for children and adolescents20168173210.1016/j.jcpo.2016.03.007Open DOISearch in Google Scholar
Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, et al; British Childhood Cancer Survivor Study Steering Group. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010; 304: 172-9. doi: 10.1001/jama.2010.923ReulenRCWinterDLFrobisherCLancashireERStillerCAJenneyMEetal; British Childhood Cancer Survivor Study Steering GroupLong-term cause-specific mortality among survivors of childhood cancer2010304172910.1001/jama.2010.92320628130Open DOISearch in Google Scholar
Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009; 101: 806-13. doi: 10.1093/ jnci/djp104OlsenJHMöllerTAndersonHLangmarkFSankilaRTryggvadóttírLet alLifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries20091018061310.1093/jnci/djp10419470947Open DOISearch in Google Scholar
Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al, British Childhood Cancer Survivor Study Steering Group. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305: 2311-19. doi: 10.1001/jama.2011.747ReulenRCFrobisherCWinterDLKellyJLancashireERStillerCAetalBritishChildhood Cancer Survivor Study Steering GroupLong-term risks of subsequent primary neoplasms among survivors of childhood cancer201130523111910.1001/jama.2011.74721642683Open DOISearch in Google Scholar
Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001; 93: 618-29. doi: 10.1093/jnci/93.8.618NegliaJPFriedmanDLYasuiYMertensACHammondSStovallMet alSecond malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study2001936182910.1093/jnci/93.8.61811309438Open DOISearch in Google Scholar
Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009; 27: 2356-62. doi: 10.1200/JCO.2008.21.1920MeadowsATFriedmanDLNegliaJPMertensACDonaldsonSSStovallMet alSecond neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort20092723566210.1200/JCO.2008.21.1920273864519255307Open DOISearch in Google Scholar
Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102: 1083-95. doi: 10.1093/jnci/djq238FriedmanDLWhittonJLeisenringWMertensACHammondSStovallMet alSubsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study201010210839510.1093/jnci/djq238290740820634481Open DOISearch in Google Scholar
Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, et al. Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015. JAMA 2017; 317: 814-24. doi: 10.1001/jama.2017.0693TurcotteLMLiuQYasuiYArnoldMAHammondSHowellRMet alTemporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-201520173178142410.1001/jama.2017.0693Open DOISearch in Google Scholar
Turcotte LM, Whitton JA, Friedman DL, Hammond S, Armstrong GT, Leisenring W, et al. Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort. J Clin Oncol 2015; 33: 3568-75. doi: 10.1200/JCO.2015.60.9487TurcotteLMWhittonJAFriedmanDLHammondSArmstrongGTLeisenringWet alRisk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort20153335687510.1200/JCO.2015.60.9487Open DOISearch in Google Scholar
Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, et al. DCOG LATER Study Group. Longterm risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study Cohort: role of chemotherapy. J Clin Oncol 2017; 35: 2288-98. doi: 10.1200/JCO.2016.71.6902TeepenJCvan LeeuwenFETissingWJvan Dulmen-denBroeder Evan denHeuvel-Eibrink MMvan derPal HJet alDCOG LATER Study Group20173522889810.1200/JCO.2016.71.6902Open DOISearch in Google Scholar
Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, et al. DCOG-LATER Study Group. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control 2019; 30: 909-22. doi: 10.1007/s10552-019-01204-zTeepenJCKremerLCvan derHeiden-van der Loo MTissingWJvan derPal HJvan denHeuvel-Eibrink MMet alDCOG-LATER Study Group2019309092210.1007/s10552-019-01204-zOpen DOISearch in Google Scholar
Jazbec J, Ećimović P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574-81. doi: 10.1002/pbc.20025JazbecJEćimovićPJerebBSecond neoplasms after treatment of childhood cancer in Slovenia2004425748110.1002/pbc.20025Open DOISearch in Google Scholar
Jereb B. Model for long-term follow-up of survivors of childhood cancer. Med Pediatr Oncol 2000; 34: 256-8. doi: 10.1002/(sici)1096-911x(200004)34:4<256::aid-mpo5>3.0.co;2-8JerebBModel for long-term follow-up of survivors of childhood cancer200034256810.1002/(sici)1096-911x(200004)34:4<256::aid-mpo5>3.0.co;2-8Open DOISearch in Google Scholar
International Classification of Diseases for Oncology. Third Edition, First Revision. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al, editors. Geneva: World Health Organization; 2013.Third Edition, First RevisionFritzAPercyCJackAShanmugaratnamKSobinLParkinDMet al, editorsGenevaWorld Health Organization;2013Search in Google Scholar
Cancer registration: principles and methods. Jensen OM, Parkin DM, MacLennan R, Muir C, Skeet RG, editors. Lyon, France: World Health Organization, IARC Sci Publ; 1991. p. 95.JensenOMParkinDMMacLennanRMuirCSkeetRGeditorsLyon, FranceWorld Health Organization, IARC Sci Publ;1991p95Search in Google Scholar
dos Santos Silva I. Cancer epidemiology: principles and methods. First edition. Lyon: International Agency for Research on Cancer, World Health Organization; 1999.dosSantos Silva ILyonInternational Agency for Research on Cancer, World Health Organization;1999Search in Google Scholar
Thernau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York, NY: Springer-Verlag; 2000. doi.org/10.1007/978-1-4757-3294-8ThernauTMGrambschPMNew York, NYSpringer-Verlag2000doi.org/10.1007/978-1-4757-3294-810.1007/978-1-4757-3294-8Search in Google Scholar
Dickman PW, Coviello E. “Estimating and modeling relative survival.” Stata J 2015; 15: 186-215. doi: 10.1177/1536867X1501500112DickmanPWCovielloE.“Estimating and modeling relative survival.”20151518621510.1177/1536867X1501500112Open DOISearch in Google Scholar
Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, et al. Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review. J Clin Oncol 2018; 36: 2145-52. doi: 10.1200/JCO.2017.76.7764TurcotteLMNegliaJPReulenRCRonckersCMvan LeeuwenFEMortonLMet alRisk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review20183621455210.1200/JCO.2017.76.7764Open DOISearch in Google Scholar
Jairam V, Roberts KB, Yu JB. Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys 2013; 85: e151-5. doi: 10.1016/j.ijrobp.2012.10.007JairamVRobertsKBYuJBHistorical trends in the use of radiation therapy for pediatric cancers: 1973-2008201385e151510.1016/j.ijrobp.2012.10.007Open DOISearch in Google Scholar
Richards S, Pui CH, Gayon P; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG). Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2013; 60: 185-95. doi: 10.1002/pbc.24228RichardsSPuiCHGayonP; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG)Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia2013601859510.1002/pbc.24228346108422693038Open DOISearch in Google Scholar
Vora A, Andreano A, Pui CH, Hunger SP, Schrappe M, Moericke A, et al. Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy. J Clin Oncol 2016; 34: 919-26. doi: 10.1200/JCO.2015.64.2850VoraAAndreanoAPuiCHHungerSPSchrappeMMoerickeAet alInfluence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy2016349192610.1200/JCO.2015.64.2850487199826755523Open DOISearch in Google Scholar
Pritchard-Jones K. Childhood cancer in Britain: incidence, survival, and mortality. Br J Cancer 2007; 96: 1927. doi: 10.1038/sj.bjc.6603800Pritchard-JonesK.Childhood cancer in Britain: incidence, survival, and mortality200796192710.1038/sj.bjc.6603800Open DOISearch in Google Scholar
Abramson DH. Retinoblastoma in the 20th Century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005; 46: 268491. doi: 10.1167/iovs.04-1462AbramsonDHRetinoblastoma in the 20th Century: past success and future challenges the Weisenfeld lecture20054626849110.1167/iovs.04-146216043839Open DOISearch in Google Scholar
Schonfeld SJ, Kleinerman RA, Abramson DH, Seddon JM, Tucker MA, Morton LM. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer 2021; 124: 1312-19. doi: 10.1038/s41416-020-01248-ySchonfeldSJKleinermanRAAbramsonDHSeddonJMTuckerMAMortonLMLong-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors202112413121910.1038/s41416-020-01248-y800757433473166Open DOISearch in Google Scholar
Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, et al. PanCareSurFup Consortium. Risk of soft-tissue sarcoma among 69,460 five-year survivors of childhood cancer in Europe. J Natl Cancer Inst 2018; 110: 649–66. doi: 10.1093/jnci/djx235BrightCJHawkinsMMWinterDLAlessiDAllodjiRSBagnascoFet alPanCareSurFup Consortium20181106496610.1093/jnci/djx235600501929165710Open DOISearch in Google Scholar
Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, et al. Risk of subsequent bone cancers among 69,460 five-year survivors of childhood and adolescent cancer in Europe. J Natl Cancer Inst 2018; 110: 183-94. doi: 10.1093/jnci/djx165. PMID: 28954302FidlerMMReulenRCWinterDLAllodjiRSBagnascoFBárdiEet alRisk of subsequent bone cancers among 69,460 five-year survivors of childhood and adolescent cancer in Europe20181101839410.1093/jnci/djx165.PMID:28954302Open DOISearch in Google Scholar
Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2007; 99: 300-8. doi: 10.1093/jnci/djk052HendersonTOWhittonJStovallMMertensACMitbyPFriedmanDet alSecondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study200799300810.1093/jnci/djk05217312307Open DOISearch in Google Scholar
Garwicz S, Anderson H, Olsen JH, Døllner H, Hertz H, Jonmundsson G, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. Int J Cancer 2000; 88: 672-8. doi: 10.1002/1097-0215(20001115)88:4<672::aid-ijc24>3.0.co;2-nGarwiczSAndersonHOlsenJHDøllnerHHertzHJonmundssonGet alSecond malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries200088672810.1002/1097-0215(20001115)88:4<672::aid-ijc24>3.0.co;2-nOpen DOISearch in Google Scholar
Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup. Eur J Cancer 2019; 117: 71-83. doi: 10.1016/j.ejca.2019.05.013AllodjiRSHawkinsMMBrightCJFidler-BenaoudiaMMWinterDLAlessiDet alRisk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup2019117718310.1016/j.ejca.2019.05.013Open DOISearch in Google Scholar
Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, et al. Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood 2011; 117: 6315-8. doi: 10.1182/blood-2011-02-335158NottageKLanctotJLiZNegliaJPBhatiaSHammondSet alLong-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study20111176315810.1182/blood-2011-02-335158312294921498675Open DOISearch in Google Scholar
Bagnasco F, Caruso S, Andreano A, Valsecchi MG, Jankovic M, Biondi A, et al. OTR-AIEOP Registry. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer 2019; 110: 86-97. doi: 10.1016/j.ejca.2018.12.021BagnascoFCarusoSAndreanoAValsecchiMGJankovicMBiondiAet alOTR-AIEOP Registry2019110869710.1016/j.ejca.2018.12.02130772657Open DOISearch in Google Scholar